Novel Peptide from an Odorous Frog Provides Strategies for Intervention in Skin Wound Healing
Chao Li,Zhe Fu,Tao Jin,Yixiang Liu,Naixin Liu,Saige Yin,Zhuo Wang,Yubin Huang,Yinglei Wang,Yingxuan Zhang,Jiayi Li,Yutong Wu,Ying Yang,Jing Tang,Ying Wang,Xinwang Yang
DOI: https://doi.org/10.2139/ssrn.4229895
2022-01-01
SSRN Electronic Journal
Abstract:Amphibian-derived pro-healing peptides provide a novel strategy for the treatment of skin wounds, not only as drug candidates, but also as molecular probes for the elucidation of new molecular mechanisms and discovery of drug targets. Here, a novel non-toxic peptide (OA-RD17) was identified from frog skin tissue. Results showed that OA-RD17 promoted macrophage proliferation and migration by activating MAPK and suppressed inflammation by inhibiting NF-κB. In keratinocytes, OA-RD17 inhibited inflammation, and activated MAPK via the TLR4 receptor to promote proliferation and migration and up-regulate the expression of miR-632, which targeted GSK3β to activate Wnt/β-catenin to boost proliferation and migration in a positive feedback manner. Notably, OA-RD17 promoted transition from the inflammatory to proliferative stage, accelerated epidermal and granulation tissue regeneration, and exhibited therapeutic effects on mouse and diabetic patient ex vivo skin wounds. MiR-632 activated Wnt/β-catenin to promote full-thickness skin wound healing in rats. Using OA-RD17 as a molecular probe, our study firstly provides evidence that ‘TLR4/MAPK’ and ‘Wnt/β-catenin’ are closely involved in skin wound healing. In addition, our results indicate that OA-RD17 and miR-632 are promising pro-healing drug candidates.Funding: This work was supported by grants from the National Natural Science Foundation of China (32060212, 81760648, and 82160159), Project of Yunnan Applied Basic Research Project-Kunming Medical University Union Foundation (202101AY070001- 006), Yunnan Applied Basic Research Project Foundation (2019FB128), Innovative Team of Precise Prevention and Treatment against Metabolic of Yunnan University, Key Project of Construction of Clinical Center of Yunnan Provincial Health Commission (ZX20191001), and Construction Projects of Yunnan Orthopedics and Sports Rehabilitation Clinical Medicine Research Center (202102AA310068).Declaration of Interest: The authors declare no competing financial interestEthical Approval: All animal care and handling procedures were approved and performed in accordance with the Kunming Medical University Ethics Committee (kmmu20220069). The collection of human skin was approved by the Ethics Committee of the Affiliated Hospital ofYunnan University (2021103). Written informed consent was provided by all patients, confirming the voluntary donation of their skin for the wound healing study without any financial remuneration.